Background illustration for clinical trials search

Paid Clinical Trials Denver

Discover 1,569 paid clinical trials in Denver, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Denver CO, Aurora CO, Saint Louis MO, Houston TX,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase 1, Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT04910568

Phase 1, Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma (MM), Multiple Myeloma Refractory,
Location: Denver CO, Las Vegas NV, Eugene OR, Nashville TN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07637578

Phase 2, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Goodyear AZ, St Louis MO, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase 2, Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Denver CO, Atlanta GA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06768489

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

for
Lymphoma, Non-Hodgkin, Lymphoma, Follicular,
Location: Denver CO, Los Angeles CA, Nashville TN, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07519772

Phase 1, Phase 2, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Santa Fe NM, Salt Lake City UT, Lubbock TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Denver CO, Scottsdale AZ, Dallas TX, Rochester MN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase 1, Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Denver CO, Los Angeles CA, Houston TX, Nashville TN,
Sponsor: Prelude Therapeutics Incorporated

Sex: All

Age: 18+

Code: NCT07469891

Phase 1, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Kansas City KS,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase 3, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Phoenix AZ, Iowa City IA,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase 2, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Denver CO, Aurora CO, Salt Lake City UT, Omaha NE,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase 3, Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Denver CO, Austin TX, San Antonio TX, San Diego CA,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase 1, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Denver CO, Aurora CO, Albuquerque NM, Fairway KS,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Denver CO, Salt Lake City UT, Phoenix AZ, Dallas TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Denver CO, Salt Lake City UT, Irving TX, Austin TX,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Denver CO, Nashville TN, New Orleans LA, Orlando FL
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Denver CO, Dallas TX, Iowa City IA, Madison WI,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase 2, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Denver CO, St Louis MO, San Antonio TX, Duarte CA,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase 2, Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

for
Waldenstrom Macroglobulinemia
Location: Denver CO, Dallas TX, Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06561347

Phase 2, Recruiting

Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.

Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.

Why choose Denver for clinical trials?

Denver boasts a diverse population which helps increase the reliability and relevance of research outcomes. The city is also home to top-tier medical research facilities known for innovative approaches to healthcare and a strong emphasis on medical breakthroughs.

Choosing to participate in a clinical trial in Denver means contributing to vital medical research while benefiting from a well-coordinated and supportive clinical research infrastructure. This environment not only promotes advancements in medical science but also provides participants with access to pioneering therapies and specialized care throughout the study.

Common conditions studied in Denver

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Denver